Drug-induced thrombocytopenia and thrombosis: Evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-10

AUTHORS

Benjamin M. Scirica, Christopher P. Cannon, Richard Cooper, Richard H. Aster, Jacqueline Brassard, Carolyn H. McCabe, Andrew Charlesworth, Allan M. Skene, Eugene Braunwald

ABSTRACT

OBJECTIVE: To assess etiology and impact of thrombocytopenia in a large oral glycoprotein (GP) IIb/IIIa inhibitor trial. BACKGROUND: Heparin is known to cause thrombocytopenia, and in some of these patients thrombosis. GP IIb/IIIa inhibitors are also associated with thrombocytopenia. METHODS: The Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) Trial randomized 10,392 patients with ACS to the oral GP IIb/IIIa inhibitor orbofiban or placebo. Patients were followed for a minimum of ten months. Thrombocytopenia was defined prospectively as a platelet count < 80,000. RESULTS: Thrombocytopenia was rare in the OPUS-TIMI 16 trial (0.68% at Day 30 and 0.80% at 1 year), but more common in patients treated with orbofiban (0.92%) compared with those treated with placebo (0.2%), p < 0.001. Patients who developed thrombocytopenia had higher rates of death (11.6% vs. 1.7%, p < 0.001), recurrent MI (12.1% vs. 2.8%, p < 0.001), intracranial hemorrhage (2.9% vs. 0.0%, p < 0.001), and major or severe bleeding (19.0% vs. 2.0%, p < 0.001) at 30 days (with similar results at one year). CONCLUSION: Thrombocytopenia, though uncommon, was associated with orbofiban use and an increased risk of bleeding, but also death and MI. This study provides further evidence that drugs that lead to thrombocytopenia are, in a significant proportion of patients associated with thrombotic events. More... »

PAGES

95-102

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11239-006-8669-4

DOI

http://dx.doi.org/10.1007/s11239-006-8669-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1039729055

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17008974


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Alanine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angina, Unstable", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aspirin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardial Infarction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Aggregation Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Glycoprotein GPIIb-IIIa Complex", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrrolidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombocytopenia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombosis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Brigham and Women's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.62560.37", 
          "name": [
            "TIMI Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital, 75 Francis st., 02115, Boston, MA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scirica", 
        "givenName": "Benjamin M.", 
        "id": "sg:person.01251365345.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251365345.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Brigham and Women's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.62560.37", 
          "name": [
            "TIMI Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital, 75 Francis st., 02115, Boston, MA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cannon", 
        "givenName": "Christopher P.", 
        "id": "sg:person.01172544713.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172544713.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical College of Wisconsin", 
          "id": "https://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Health Policy Institute, Medical College of Wisconsin, Wisconsin"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cooper", 
        "givenName": "Richard", 
        "id": "sg:person.0603114260.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603114260.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bloodcenter of Wisconsin", 
          "id": "https://www.grid.ac/institutes/grid.280427.b", 
          "name": [
            "Blood Research Institute, The Blood Center of Southeast Wisconsin, Wisconsin"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aster", 
        "givenName": "Richard H.", 
        "id": "sg:person.015510362157.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015510362157.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pfizer (United States)", 
          "id": "https://www.grid.ac/institutes/grid.410513.2", 
          "name": [
            "Pharmacia, Skokie, IL"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brassard", 
        "givenName": "Jacqueline", 
        "id": "sg:person.01260405160.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260405160.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Brigham and Women's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.62560.37", 
          "name": [
            "TIMI Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital, 75 Francis st., 02115, Boston, MA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McCabe", 
        "givenName": "Carolyn H.", 
        "id": "sg:person.0647744174.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647744174.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Nottingham Clinical Research Group, Nottingham, England"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Charlesworth", 
        "givenName": "Andrew", 
        "id": "sg:person.01342115477.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342115477.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Nottingham Clinical Research Group, Nottingham, England"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Skene", 
        "givenName": "Allan M.", 
        "id": "sg:person.0673433032.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673433032.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Brigham and Women's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.62560.37", 
          "name": [
            "TIMI Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital, 75 Francis st., 02115, Boston, MA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Braunwald", 
        "givenName": "Eugene", 
        "id": "sg:person.01016436204.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016436204.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1182/blood-2002-02-0471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000542485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0049-3848(01)00300-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008558694"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(99)00370-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009101661"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.99.22.2892", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012501908"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mhj.2000.106615", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013866463"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(98)00252-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014505465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199805213382103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015079775"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(99)00235-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018153904"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000127867.41621.85", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018742911"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(00)00919-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019410631"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(99)00778-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020477248"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.281.15.1407", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023958807"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2005.08.066", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025023328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0735-1097(94)90634-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025598401"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.103.2.201", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030101166"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.103.13.1727", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030780720"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1040-8428(98)00044-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032289211"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(99)11179-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034938491"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0092-8674(91)90458-b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042271348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.102.2.149", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042703679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200005043421803", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047561978"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood.v99.10.3540", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049249001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0008-6363(99)00253-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054580556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(97)84511-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054658752"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074488288", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075114469", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0037-1613330", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075218441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082578846", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083335832", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083343953", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-10", 
    "datePublishedReg": "2006-10-01", 
    "description": "OBJECTIVE: To assess etiology and impact of thrombocytopenia in a large oral glycoprotein (GP) IIb/IIIa inhibitor trial.\nBACKGROUND: Heparin is known to cause thrombocytopenia, and in some of these patients thrombosis. GP IIb/IIIa inhibitors are also associated with thrombocytopenia.\nMETHODS: The Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) Trial randomized 10,392 patients with ACS to the oral GP IIb/IIIa inhibitor orbofiban or placebo. Patients were followed for a minimum of ten months. Thrombocytopenia was defined prospectively as a platelet count < 80,000.\nRESULTS: Thrombocytopenia was rare in the OPUS-TIMI 16 trial (0.68% at Day 30 and 0.80% at 1 year), but more common in patients treated with orbofiban (0.92%) compared with those treated with placebo (0.2%), p < 0.001. Patients who developed thrombocytopenia had higher rates of death (11.6% vs. 1.7%, p < 0.001), recurrent MI (12.1% vs. 2.8%, p < 0.001), intracranial hemorrhage (2.9% vs. 0.0%, p < 0.001), and major or severe bleeding (19.0% vs. 2.0%, p < 0.001) at 30 days (with similar results at one year).\nCONCLUSION: Thrombocytopenia, though uncommon, was associated with orbofiban use and an increased risk of bleeding, but also death and MI. This study provides further evidence that drugs that lead to thrombocytopenia are, in a significant proportion of patients associated with thrombotic events.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11239-006-8669-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2529602", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1113719", 
        "issn": [
          "0929-5305", 
          "1573-742X"
        ], 
        "name": "Journal of Thrombosis and Thrombolysis", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "name": "Drug-induced thrombocytopenia and thrombosis: Evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial", 
    "pagination": "95-102", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "bd403ed0a16cbb6afb1f202a29fbc0e43efcb7adeff0e253d550dfe7da985d2a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17008974"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9502018"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11239-006-8669-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1039729055"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11239-006-8669-4", 
      "https://app.dimensions.ai/details/publication/pub.1039729055"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000523.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11239-006-8669-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11239-006-8669-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11239-006-8669-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11239-006-8669-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11239-006-8669-4'


 

This table displays all metadata directly associated to this object as RDF triples.

285 TRIPLES      21 PREDICATES      74 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11239-006-8669-4 schema:about N09f551b9c351499e88819d59715e3c62
2 N1012c4138c704993ab90c85f81af07e5
3 N20b2a70107784e8395b17e593cba4289
4 N3112c2e57e234c38810f9d712e056355
5 N46b1f9a28a9441d8af647ad3361c133b
6 N5b21f73fca1241508b9eefd71cb0129d
7 N5eda6b51d70a404f9f9f8ec10a6401c7
8 N670b8b90a46445fcbb5f8ce50249f8a7
9 Na534c005bbeb4ec4a793a2b546ef4d9f
10 Nb692b88384d44802be25b6e06a691064
11 Ndbaaa07d985e4cf886d205da2383f64e
12 Ndfe3065186674a6bbb07a11647b023fe
13 Ne3b09742c65b4d69803a95dbe0a757d3
14 Nf007a25325f945afaf5562f0aa284024
15 Nf4866c2eb92948468e476cadc351289f
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author N9f4e396049a54e498b31032e529af380
19 schema:citation https://app.dimensions.ai/details/publication/pub.1074488288
20 https://app.dimensions.ai/details/publication/pub.1075114469
21 https://app.dimensions.ai/details/publication/pub.1082578846
22 https://app.dimensions.ai/details/publication/pub.1083335832
23 https://app.dimensions.ai/details/publication/pub.1083343953
24 https://doi.org/10.1001/jama.281.15.1407
25 https://doi.org/10.1016/0092-8674(91)90458-b
26 https://doi.org/10.1016/0735-1097(94)90634-3
27 https://doi.org/10.1016/j.amjcard.2005.08.066
28 https://doi.org/10.1016/s0002-9149(99)00235-0
29 https://doi.org/10.1016/s0002-9149(99)00370-7
30 https://doi.org/10.1016/s0002-9149(99)00778-x
31 https://doi.org/10.1016/s0008-6363(99)00253-9
32 https://doi.org/10.1016/s0049-3848(01)00300-0
33 https://doi.org/10.1016/s0140-6736(99)11179-6
34 https://doi.org/10.1016/s0735-1097(00)00919-0
35 https://doi.org/10.1016/s0735-1097(97)84511-1
36 https://doi.org/10.1016/s0735-1097(98)00252-6
37 https://doi.org/10.1016/s1040-8428(98)00044-4
38 https://doi.org/10.1055/s-0037-1613330
39 https://doi.org/10.1056/nejm199805213382103
40 https://doi.org/10.1056/nejm200005043421803
41 https://doi.org/10.1067/mhj.2000.106615
42 https://doi.org/10.1161/01.cir.0000127867.41621.85
43 https://doi.org/10.1161/01.cir.102.2.149
44 https://doi.org/10.1161/01.cir.103.13.1727
45 https://doi.org/10.1161/01.cir.103.2.201
46 https://doi.org/10.1161/01.cir.99.22.2892
47 https://doi.org/10.1182/blood-2002-02-0471
48 https://doi.org/10.1182/blood.v99.10.3540
49 schema:datePublished 2006-10
50 schema:datePublishedReg 2006-10-01
51 schema:description OBJECTIVE: To assess etiology and impact of thrombocytopenia in a large oral glycoprotein (GP) IIb/IIIa inhibitor trial. BACKGROUND: Heparin is known to cause thrombocytopenia, and in some of these patients thrombosis. GP IIb/IIIa inhibitors are also associated with thrombocytopenia. METHODS: The Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) Trial randomized 10,392 patients with ACS to the oral GP IIb/IIIa inhibitor orbofiban or placebo. Patients were followed for a minimum of ten months. Thrombocytopenia was defined prospectively as a platelet count < 80,000. RESULTS: Thrombocytopenia was rare in the OPUS-TIMI 16 trial (0.68% at Day 30 and 0.80% at 1 year), but more common in patients treated with orbofiban (0.92%) compared with those treated with placebo (0.2%), p < 0.001. Patients who developed thrombocytopenia had higher rates of death (11.6% vs. 1.7%, p < 0.001), recurrent MI (12.1% vs. 2.8%, p < 0.001), intracranial hemorrhage (2.9% vs. 0.0%, p < 0.001), and major or severe bleeding (19.0% vs. 2.0%, p < 0.001) at 30 days (with similar results at one year). CONCLUSION: Thrombocytopenia, though uncommon, was associated with orbofiban use and an increased risk of bleeding, but also death and MI. This study provides further evidence that drugs that lead to thrombocytopenia are, in a significant proportion of patients associated with thrombotic events.
52 schema:genre research_article
53 schema:inLanguage en
54 schema:isAccessibleForFree false
55 schema:isPartOf N1b19d72c10d146448d16d917192b5b2e
56 N6a4d08ec4fe64b8085db3e9ab0c46ab1
57 sg:journal.1113719
58 schema:name Drug-induced thrombocytopenia and thrombosis: Evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial
59 schema:pagination 95-102
60 schema:productId N0ff5846f83654eb0a15b93f9848c91fb
61 N4670d8765eb64d9da8cb12a4f11f5847
62 Na684b81e768247ccad804ed623d91400
63 Nae07beef05754ae881de91a000375943
64 Ne671d254e4a3439e9b59d52170857808
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039729055
66 https://doi.org/10.1007/s11239-006-8669-4
67 schema:sdDatePublished 2019-04-10T21:39
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher Nb1dd523b76d642f78470eb82c4c39c9d
70 schema:url http://link.springer.com/10.1007%2Fs11239-006-8669-4
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N09f551b9c351499e88819d59715e3c62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Pyrrolidines
76 rdf:type schema:DefinedTerm
77 N0ff5846f83654eb0a15b93f9848c91fb schema:name pubmed_id
78 schema:value 17008974
79 rdf:type schema:PropertyValue
80 N1012c4138c704993ab90c85f81af07e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Humans
82 rdf:type schema:DefinedTerm
83 N1b19d72c10d146448d16d917192b5b2e schema:issueNumber 2
84 rdf:type schema:PublicationIssue
85 N20b2a70107784e8395b17e593cba4289 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Thrombocytopenia
87 rdf:type schema:DefinedTerm
88 N21d1c9a6f33e497c947c4e877948ed6d schema:name Nottingham Clinical Research Group, Nottingham, England
89 rdf:type schema:Organization
90 N3112c2e57e234c38810f9d712e056355 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Alanine
92 rdf:type schema:DefinedTerm
93 N4670d8765eb64d9da8cb12a4f11f5847 schema:name doi
94 schema:value 10.1007/s11239-006-8669-4
95 rdf:type schema:PropertyValue
96 N46b1f9a28a9441d8af647ad3361c133b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Myocardial Infarction
98 rdf:type schema:DefinedTerm
99 N4bf0bd766250489098b22cb45c7dc3e7 rdf:first sg:person.01342115477.98
100 rdf:rest Nb0c15eb8086040ed822876ebb78fb3c6
101 N4d2f278d8d8441e595a8b2063f9f6479 rdf:first sg:person.0603114260.63
102 rdf:rest Ned94f4032280458691ff70d403dc08f7
103 N538160878edf418ebc428523277a4766 rdf:first sg:person.01016436204.18
104 rdf:rest rdf:nil
105 N5b21f73fca1241508b9eefd71cb0129d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Middle Aged
107 rdf:type schema:DefinedTerm
108 N5eda6b51d70a404f9f9f8ec10a6401c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Thrombosis
110 rdf:type schema:DefinedTerm
111 N670b8b90a46445fcbb5f8ce50249f8a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Male
113 rdf:type schema:DefinedTerm
114 N6a4d08ec4fe64b8085db3e9ab0c46ab1 schema:volumeNumber 22
115 rdf:type schema:PublicationVolume
116 N9f4e396049a54e498b31032e529af380 rdf:first sg:person.01251365345.81
117 rdf:rest Ne4b127e395fe4f4a9f438b990b8f4282
118 Na534c005bbeb4ec4a793a2b546ef4d9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Aged
120 rdf:type schema:DefinedTerm
121 Na684b81e768247ccad804ed623d91400 schema:name readcube_id
122 schema:value bd403ed0a16cbb6afb1f202a29fbc0e43efcb7adeff0e253d550dfe7da985d2a
123 rdf:type schema:PropertyValue
124 Nac9f3307cebc499bb578cd73056c802e schema:name Nottingham Clinical Research Group, Nottingham, England
125 rdf:type schema:Organization
126 Nae07beef05754ae881de91a000375943 schema:name dimensions_id
127 schema:value pub.1039729055
128 rdf:type schema:PropertyValue
129 Nb0c15eb8086040ed822876ebb78fb3c6 rdf:first sg:person.0673433032.58
130 rdf:rest N538160878edf418ebc428523277a4766
131 Nb1dd523b76d642f78470eb82c4c39c9d schema:name Springer Nature - SN SciGraph project
132 rdf:type schema:Organization
133 Nb692b88384d44802be25b6e06a691064 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Aspirin
135 rdf:type schema:DefinedTerm
136 Nd6747102993e4e91818c83d42d3b7929 rdf:first sg:person.01260405160.41
137 rdf:rest Nddbec65416374dd783712f0108000a0b
138 Ndbaaa07d985e4cf886d205da2383f64e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Angina, Unstable
140 rdf:type schema:DefinedTerm
141 Nddbec65416374dd783712f0108000a0b rdf:first sg:person.0647744174.31
142 rdf:rest N4bf0bd766250489098b22cb45c7dc3e7
143 Ndfe3065186674a6bbb07a11647b023fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Kaplan-Meier Estimate
145 rdf:type schema:DefinedTerm
146 Ne3b09742c65b4d69803a95dbe0a757d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Female
148 rdf:type schema:DefinedTerm
149 Ne4b127e395fe4f4a9f438b990b8f4282 rdf:first sg:person.01172544713.06
150 rdf:rest N4d2f278d8d8441e595a8b2063f9f6479
151 Ne671d254e4a3439e9b59d52170857808 schema:name nlm_unique_id
152 schema:value 9502018
153 rdf:type schema:PropertyValue
154 Ned94f4032280458691ff70d403dc08f7 rdf:first sg:person.015510362157.72
155 rdf:rest Nd6747102993e4e91818c83d42d3b7929
156 Nf007a25325f945afaf5562f0aa284024 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Platelet Glycoprotein GPIIb-IIIa Complex
158 rdf:type schema:DefinedTerm
159 Nf4866c2eb92948468e476cadc351289f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Platelet Aggregation Inhibitors
161 rdf:type schema:DefinedTerm
162 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
163 schema:name Medical and Health Sciences
164 rdf:type schema:DefinedTerm
165 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
166 schema:name Clinical Sciences
167 rdf:type schema:DefinedTerm
168 sg:grant.2529602 http://pending.schema.org/fundedItem sg:pub.10.1007/s11239-006-8669-4
169 rdf:type schema:MonetaryGrant
170 sg:journal.1113719 schema:issn 0929-5305
171 1573-742X
172 schema:name Journal of Thrombosis and Thrombolysis
173 rdf:type schema:Periodical
174 sg:person.01016436204.18 schema:affiliation https://www.grid.ac/institutes/grid.62560.37
175 schema:familyName Braunwald
176 schema:givenName Eugene
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016436204.18
178 rdf:type schema:Person
179 sg:person.01172544713.06 schema:affiliation https://www.grid.ac/institutes/grid.62560.37
180 schema:familyName Cannon
181 schema:givenName Christopher P.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172544713.06
183 rdf:type schema:Person
184 sg:person.01251365345.81 schema:affiliation https://www.grid.ac/institutes/grid.62560.37
185 schema:familyName Scirica
186 schema:givenName Benjamin M.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251365345.81
188 rdf:type schema:Person
189 sg:person.01260405160.41 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
190 schema:familyName Brassard
191 schema:givenName Jacqueline
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260405160.41
193 rdf:type schema:Person
194 sg:person.01342115477.98 schema:affiliation N21d1c9a6f33e497c947c4e877948ed6d
195 schema:familyName Charlesworth
196 schema:givenName Andrew
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342115477.98
198 rdf:type schema:Person
199 sg:person.015510362157.72 schema:affiliation https://www.grid.ac/institutes/grid.280427.b
200 schema:familyName Aster
201 schema:givenName Richard H.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015510362157.72
203 rdf:type schema:Person
204 sg:person.0603114260.63 schema:affiliation https://www.grid.ac/institutes/grid.30760.32
205 schema:familyName Cooper
206 schema:givenName Richard
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603114260.63
208 rdf:type schema:Person
209 sg:person.0647744174.31 schema:affiliation https://www.grid.ac/institutes/grid.62560.37
210 schema:familyName McCabe
211 schema:givenName Carolyn H.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647744174.31
213 rdf:type schema:Person
214 sg:person.0673433032.58 schema:affiliation Nac9f3307cebc499bb578cd73056c802e
215 schema:familyName Skene
216 schema:givenName Allan M.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673433032.58
218 rdf:type schema:Person
219 https://app.dimensions.ai/details/publication/pub.1074488288 schema:CreativeWork
220 https://app.dimensions.ai/details/publication/pub.1075114469 schema:CreativeWork
221 https://app.dimensions.ai/details/publication/pub.1082578846 schema:CreativeWork
222 https://app.dimensions.ai/details/publication/pub.1083335832 schema:CreativeWork
223 https://app.dimensions.ai/details/publication/pub.1083343953 schema:CreativeWork
224 https://doi.org/10.1001/jama.281.15.1407 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023958807
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1016/0092-8674(91)90458-b schema:sameAs https://app.dimensions.ai/details/publication/pub.1042271348
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1016/0735-1097(94)90634-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025598401
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1016/j.amjcard.2005.08.066 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025023328
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/s0002-9149(99)00235-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018153904
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/s0002-9149(99)00370-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009101661
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/s0002-9149(99)00778-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1020477248
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/s0008-6363(99)00253-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054580556
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1016/s0049-3848(01)00300-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008558694
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1016/s0140-6736(99)11179-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034938491
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1016/s0735-1097(00)00919-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019410631
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1016/s0735-1097(97)84511-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054658752
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1016/s0735-1097(98)00252-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014505465
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1016/s1040-8428(98)00044-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032289211
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1055/s-0037-1613330 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075218441
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1056/nejm199805213382103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015079775
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1056/nejm200005043421803 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047561978
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1067/mhj.2000.106615 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013866463
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1161/01.cir.0000127867.41621.85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018742911
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1161/01.cir.102.2.149 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042703679
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1161/01.cir.103.13.1727 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030780720
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1161/01.cir.103.2.201 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030101166
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1161/01.cir.99.22.2892 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012501908
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1182/blood-2002-02-0471 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000542485
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1182/blood.v99.10.3540 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049249001
273 rdf:type schema:CreativeWork
274 https://www.grid.ac/institutes/grid.280427.b schema:alternateName Bloodcenter of Wisconsin
275 schema:name Blood Research Institute, The Blood Center of Southeast Wisconsin, Wisconsin
276 rdf:type schema:Organization
277 https://www.grid.ac/institutes/grid.30760.32 schema:alternateName Medical College of Wisconsin
278 schema:name Health Policy Institute, Medical College of Wisconsin, Wisconsin
279 rdf:type schema:Organization
280 https://www.grid.ac/institutes/grid.410513.2 schema:alternateName Pfizer (United States)
281 schema:name Pharmacia, Skokie, IL
282 rdf:type schema:Organization
283 https://www.grid.ac/institutes/grid.62560.37 schema:alternateName Brigham and Women's Hospital
284 schema:name TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital, 75 Francis st., 02115, Boston, MA
285 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...